Market Cap | 185.47K | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
Income | -409.64k | Forward P/E | - | EPS next Y | - | 50D Avg Chg | - |
Sales | 397.69k | PEG | - | EPS past 5Y | - | 200D Avg Chg | -91.00% |
Dividend | N/A | Price/Book | N/A | EPS next 5Y | - | 52W High Chg | -97.00% |
Recommedations | - | Quick Ratio | 0.45 | Shares Outstanding | 84.30M | 52W Low Chg | - |
Insider Own | 57.38% | ROA | -35.54% | Shares Float | 35.53M | Beta | 1.21 |
Inst Own | - | ROE | -285.20% | Shares Shorted/Prior | -/- | Price | 0.00010 |
Gross Margin | 20.66% | Profit Margin | -103.00% | Avg. Volume | - | Target Price | - |
Oper. Margin | -333.49% | Earnings Date | - | Volume | 1,300 | Change | 0.00% |
Medical International Technology, Inc. produces, markets, and sells needle-free jet injector products for use in humans and animals. It offers Med-Jet model needle-free injection systems for medical, cosmetic dermatology, and mesotherapy applications, as well as for single and mass vaccination in humans; Agro-Jet and Avian-Jet needle-free injection systems for small farm animal, pets clinic use, and livestock vaccination; Avian-Jet needle-free injectors for poultry vaccination; and MINI-JET for day old chick vaccination. The company sells its products to doctors, dentists, nurses, veterinarians, farmers, and home users in approximately 30 countries, including the United States. Medical International Technology, Inc. is based in Montreal, Canada.